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Objective: To estimate the association between depressive symptoms and physical dis-
eases in Switzerland, as respective findings might inform about future estimates of mental
and physical health care costs.
Methods:A population-based study, using data from the Swiss Health Survey collected by
computer-assisted telephone interviews and additional written questionnaires during the
year 2007 (n=18,760) in Switzerland. The multistage stratified random sample included
subjects aged 15 years and older, living in a private Swiss household with a telephone con-
nection. Complete data were available for 14,348 subjects (51% of all subjects reached by
telephone). Logistic regression analyses were used to estimate the associations between
depressive symptoms and any physical disease, or a specific physical disease out of 13 non-
communicable physical diseases assessed with a self-report checklist on common physical
diseases. Analyses were adjusted for sex, age, education, occupation, and household
income.
Results: In the adjusted models, depressive symptoms were associated with arthrosis and
arthritis [Odds Ratio (OR)=1.79, 95% confidence interval (CI)=1.28-2.50] and any physical
disease (OR=1.67, 95% CI=1.33-2.10) after controlling for multiple testing.
Conclusion:Our findings contribute to a better understanding of the comorbidity of depres-
sive symptoms and arthrosis and arthritis in Switzerland and might have implications for
more precise future estimates of mental and physical health care costs.
Keywords: comorbidity, co-occurrence, depressive symptoms,major depression,mental–physical,mental–somatic,
physical disease
INTRODUCTION
Depression is a global leading cause of disability (1–3), affecting
350 million people worldwide (4). According to the World Health
Organization, annually more than 36 million people die of non-
communicable physical diseases worldwide (5). Population-based
studies around the world revealed that the presence of depres-
sive symptoms is strongly associated with the presence of a wide
range of physical diseases (6). This association has especially been
reported in subjects with migraine (7, 8), asthma (7), diabetes (9,
10), chronic musculoskeletal disorders (11, 12), such as rheuma-
toid arthritis (13), stomach and duodenal ulcer (14), osteoporosis
(15), chronic obstructive pulmonary disease (COPD) (16, 17),
cardiovascular diseases (18), high blood pressure (19), myocar-
dial infarction (20), apoplexy (21), renal disease and calculi (22),
cancer (23), and allergies (24). Previous research showed that
depression is associated with a wide range of physical diseases
with the strongest association being reported with cardiovascular
Abbreviations: CI, confidence interval; CIDI-SF, Composite International Diagnos-
tic Interview Short Form; COPD, chronic obstructive pulmonary disease; OR, odds
ratio; SHS, Swiss health survey.
diseases (18), diabetes (9, 10), COPD (16), and chronic muscu-
loskeletal disorders (11, 12). However, findings on the direction of
the respective associations remain heterogeneous (25–28).
While there are a couple of studies, which assessed the patterns
of depressive symptoms and physical diseases in large (>10,000
participants) samples (6, 7, 29–31), the majority of studies com-
prised much smaller samples (e.g., in the field of depression and
arthrosis and arthritis 13). Therefore, high quality replication
studies, assessing depression in large representative nation-wide
samples are highly warranted.
While these findings cover the situation in a broad number of
low-, middle-, and large high-income countries (6), less focus has
been spent on small high-income countries, such as Switzerland
(32). Switzerland ranks among the top three countries in overall
prosperity (33) and has one of the best and most expensive health
care systems worldwide (34). Therefore, it might be interesting
to examine whether previous findings on the association between
depression and physical diseases extend to Switzerland.
Furthermore, increased life expectancy together with an overall
increased average age, not only in Switzerland (34) but also in
most other regions of the world (5), is expected to result in higher
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prevalence of physical diseases (5, 35). At the same time, the preva-
lence of mental disorders within the working population is rising
in Switzerland (36). Unfortunately, we are not yet in a position to
estimate whether the comorbidity of chronic physical diseases and
depression is about to increase as well, as the pattern of comorbid-
ity has, to the best of our knowledge, not yet been determined in
Switzerland. Our study might lay the foundation for further stud-
ies assessing the changes of mental–physical comorbidity patterns
over time, as the present data derive from a nation-wide health
survey conducted every 5 years in Switzerland.
Evidence suggests that patients suffering from physical diseases
and comorbid mental disorders show increased mortality rates,
decreased quality of life, and poorer health care outcomes as com-
pared to patients with physical diseases without comorbid mental
disorders (37, 38). Thus, scrutinizing the associations between
mental disorders and physical diseases could provide implications
for improved health care for patients with comorbid mental and
physical conditions.
The presence of depressive symptoms in subjects with a physical
disease increases treatment costs for this disease, as compared to
subjects without depressive symptoms suffering from the same dis-
ease (39–41). To date, a potential effect of depression on treatment
costs for related physical diseases was not taken into account for
precise estimates of the economic burden caused by depression in
Switzerland (42). Thus, it is essential to estimate the prevalence of
conditions comorbid with depression, and this article might there-
fore contribute to more precise future estimates of costs related to
depression in Switzerland and comparable countries.
Additionally, to estimate the costs for co-occurring depressive
symptoms and physical diseases, it is important to not simply add
the separate costs related to depressive symptoms (costs related
to depression per person, multiplied by number of subjects with
depression) to the separate costs related to physical diseases (costs
related to physical disease, multiplied by number of subjects with
physical disease), which is referred to as double counting (1).
Thus, by accounting for co-occurrence of these conditions, double
counting can be avoided. Thereby, the estimation of the preva-
lence of comorbid conditions might contribute to more precise
future estimates of costs of co-occurring depressive symptoms
and physical diseases.
The aim of this article was to estimate the association between
depressive symptoms and physical disease in Switzerland.
MATERIALS AND METHODS
DESIGN AND SAMPLE
Data were drawn from the Swiss Health Survey (SHS) conducted
by the Swiss Federal Statistical Office and carried out by the M.I.S.-
Trend S.A Institute in Lausanne and Gümligen in 2007 (43). The
data collection and storage for the SHS do not require formal
approval by an ethical committee, as this data collection, prepa-
ration, and storage are specifically permitted under Swiss law and
participants could decline to participate or withdraw at any time
(SR 431.012.1; SR 431.112.1). The authors of this manuscript
were not involved in data collection. Anonymized data for fur-
ther analysis were obtained upon signing a data confidentiality
and privacy contract from the Swiss Federal Statistical Office upon
request.
The SHS is a periodic, nation-wide, and cross-sectional survey
consisting of a computer assisted telephone interview followed by
a written questionnaire. The multistage stratified random sam-
ple included subjects aged 15 years and older, living in a private
Swiss household with a telephone connection in 2007. Out of
the 30,179 randomly selected private households a total of 18,760
subjects completed the telephone interview, corresponding to a
response rate of 66% (Figure 1). The additional written ques-
tionnaire was completed by 77% (n= 14,348) of the interview
participants (Figure 1).
The SHS, among others, provides representative data on men-
tal and physical health and healthcare utilization (43). A detailed
description of the SHS methodology and sampling has been
described elsewhere (44) and descriptive results of the SHS have
been reported in the Swiss Health Observatory of 2013 (45).
ASSESSMENT OF DEPRESSIVE SYMPTOMS
Depressive symptoms were assessed with the screening scale for
depression (46) from the World Health Organization Compos-
ite International Diagnostic Interview Short Form (CIDI-SF) in
the SHS. Participants were asked whether they felt sad, blue, or
depressed for two or more weeks during the past 12 months, fol-
lowed by a series of questions on symptoms related to depression,
such as weight gain or loss. A summary score was calculated based
on the positive responses to these symptom-related questions
(range 0–7). Subjects scoring above a cut-off of three symptoms
were screened positive for major depression. A detailed descrip-
tion of the CIDI-SF scoring has been reported elsewhere (47). The
CIDI-SF has demonstrated good performance for depression in
large community samples (48–50). Moreover, the CIDI-SF screen-
ing scale for depression demonstrated good reliability and validity
in the SHS sample (51).
ASSESSMENT OF PHYSICAL DISEASES
In the SHS, common non-communicable physical diseases were
assessed with a self-report checklist, based on the European
Health Interview Survey (52). Participants were asked whether
they received recent (more than 12 months ago) or current (dur-
ing the past 12 months) treatment by a medical doctor for each
physical disease out of a list of 13 conditions. These conditions
included migraine, asthma, diabetes, arthrosis and arthritis, stom-
ach ulcer and duodenal ulcer, osteoporosis, COPD and emphy-
sema, high blood pressure, myocardial infarction, apoplexy, renal
disease and renal calculi, cancer and blastoma, and allergies like
hay fever. Comparable checklists have shown high accord with
medical records (53, 54) and better accuracy than consultation
rates in national studies (55).
ASSESSMENT OF SOCIO-DEMOGRAPHIC MEASURES
We considered sex, age, education, occupation, and equivalized
household income as covariates as these characteristics have previ-
ously been linked to depression (56–58) and physical diseases (59).
Age was treated as categorical variable grouped into six categories:
15–30, 31–40, 41–50, 51–60, 61–70, and 71 years and above. The
educational level comprised three categories: mandatory school,
secondary school, and university (60). Occupation was catego-
rized into the four categories middle/higher senior management,
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Randomly selected 
private households
(1 person per 
household)
n = 30,179 
Eligible for 
interview
n = 28,319 (94%)
Ineligible for interview
(Total 1,860; 6%)
Inac!ve telephone number n = 849
Invalid telephone number n = 1,011
Interviewed
n = 18,760 (66% of 
those eligible for 
interview)
Non-par!cipa!on
(Total 9559; 34% of those eligible for 
interview)
Unavailable n = 3,730
Refused to par!cipate n = 5,238
Stopped interview n = 138
Language diﬃcul!es n = 445
Data available for analyses
n = 14,348 (51% of those 
eligible) 
Missing data (Total 4,412; 24% of 
those interviewed)
Addi!onal ques!onnaire
not returned n = 4,328
Missing data n = 84
FIGURE 1 | Flowchart of study participants.
office employees/other non-manual professions, small business
owners/independent craftspeople, and workpeople, based on the
Erikson–Goldthrope–Portocarero classification of occupation (60,
61). The equivalized household income, a continuous index repre-
senting a gradient between low and high income, was calculated by
dividing the monthly household income by the weighted number
of person in the household, where a weight of 1.0 was set for the
first person over 15 years, 0.5 for each additional person, and 0.3
for each child under 15 years (60, 62).
STATISTICAL ANALYSES
The goal was to assess the relationship between depressive symp-
toms and various types of physical disease. We run 14 separate
logistic regression models (unadjusted models) with depressive
symptoms (yes/no) as predictor, and each of the 13 physical dis-
eases (yes/no) or all combined diseases (“any physical disease”;
yes/no) as outcomes. We additionally ran the same 14 models,
controlling for the following covariates: sex, age, education, occu-
pation, and equivalized household income (adjusted models).
Results reported in the main test derived from the adjusted models.
Results from the unadjusted models can be found in the online
Supplementary Material (Table S1). A significance test for the
predictor depressive symptoms was obtained by comparing the
full model with the same model while excluding the predictor
depressive symptoms, using a likelihood ratio test.
All analyses were carried out with the recommended stan-
dardized sampling weights for the SHS sample (44). Descriptive
analyses were performed using the IBM Statistical Package for
Social Sciences 21 (IBM Corp. Released 2012, IBM SPSS Statistics
for Windows, Version 21.0, Armonk, NY: IBM Corp.). Regression
analyses were performed using R, version 2.14.2 (63), including
the R package survey (64). All tests were two-tailed with a signif-
icance level of 0.05. We controlled for multiple testing using the
Holm–Bonferroni method (65).
RESULTS
Complete data were available for 14,348 subjects (51% of all
subjects reached by telephone). Table 1 presents the char-
acteristics of this subsample. Of the 14,348 subjects, 740
(weighted percentage= 5.2) were screened positive for depressive
www.frontiersin.org March 2015 | Volume 3 | Article 47 | 3
Rodic et al. Depressive symptoms and physical diseases
Table 1 | Sample characteristics (n=14,348).
Socio-demographics N % (%w)
Sex
Female 8,057 56.2 (51.1)
Male 6,291 43.8 (48.9)
Age in years
15–30 2,221 15.5 (24.0)
31–40 2,589 18.0 (17.5)
41–50 2,714 18.9 (19.5)
51–60 2,354 16.4 (15.1)
61–70 2,382 16.6 (12.5)
71+ 2,088 14.6 (11.3)
Educational level
Mandatory school 1,725 12.0 (11.7)
Secondary level 8,660 60.4 (61.7)
University 3,963 27.6 (26.7)
Occupation
Workpeople 3,428 23.9 (25.4)
Small business owners/
independent craftspeople
1,164 8.1 (7.6)
Office employee/other
non-manual professions
3,497 24.4 (22.9)
Middle/higher senior
management
5,628 39.2 (38.3)
Unknown 631 4.4 (5.8)
Median (25th–75th percentile)
Equivalized household
income in CHFa
3,700 (2,500–5,333)
n (%w)
Physical diseases With depressive
symptoms
n=740
Without depressive
symptoms
n=13,608
Any physical disease 270 (35.8) 4,127 (30.4)
Migraine 46 (6.1) 315 (2.3)
Asthma 28 (3.7) 354 (2.6)
Diabetes 23 (3.1) 398 (2.9)
Arthrosis, arthritis 82 (10.9) 1,104 (8.1)
Stomach ulcer, duodenal
ulcer
16 (2.1) 124 (0.9)
Osteoporosis 30 (4.0) 327 (2.4)
COPD, emphysema 23 (3.1) 249 (1.8)
High blood pressure 80 (10.6) 1,841 (13.5)
Myocardial infarction 8 (1.1) 173 (1.3)
Apoplexy 4 (0.5) 73 (0.5)
Renal disease, renal calculi 17 (2.3) 125 (0.9)
Cancer, blastoma 28 (3.7) 216 (1.6)
Allergies, hay fever 67 (8.9) 806 (5.9)
n, unweighted number of subjects; %w, weighted percentage; CHF, Swiss Franc,
COPD, chronic obstructive pulmonary disease.
aGradient between low and high income.
symptoms. The number of subjects with specific physical diseases,
stratified by the presence/absence of depressive symptoms, is
presented in Table 1.
Table 2 | Adjusted logistic regression modelsa of physical diseases
predicted by depressive symptoms (n=14,348).
Physical disease n of subjects
with
condition
OR (95% CI) puncontrolled/
pcontrolledb
Any physical disease 4,397 1.67 (1.33, 2.10) <0.001*/–
Migraine 361 2.07 (1.27, 3.39) 0.008*/0.087
Asthma 382 1.49 (0.91, 2.44) 0.137/0.694
Diabetes 421 2.05 (1.17, 3.61) 0.023*/0.182
Arthrosis, arthritis 1,186 1.79 (1.28, 2.50) 0.002*/0.021*
Stomach ulcer, duodenal ulcer 140 1.44 (0.71, 2.94) 0.340/1.000
Osteoporosis 357 1.86 (0.91, 3.81) 0.116/0.694
COPD, emphysema 272 2.33 (1.29, 4.21) 0.012*/0.123
High blood pressure 1,921 1.29 (0.92, 1.81) 0.159/0.694
Myocardial infarction 181 0.90 (0.33, 2.45) 0.828/1.000
Apoplexy 77 1.37 (0.33, 5.83) 0.680/1.000
Renal disease, renal calculi 142 2.63 (1.31, 5.29) 0.017*/0.149
Cancer, blastoma 244 2.45 (1.40, 4.30) 0.005*/0.064
Allergies, hay fever 873 1.59 (1.05, 2.41) 0.042*/0.297
OR, odds ratio; CI, confidence interval; COPD, chronic obstructive pulmonary
disease.
*p<0.05.
aResults are adjusted for age, sex, education, occupation, and household income.
bControlled for multiple testing using Holm–Bonferroni method.
The results of the logistic regression models are presented in
Table 2. Depressive symptoms were associated with an increased
risk for migraine, diabetes, arthrosis and arthritis, COPD and
emphysema, renal disease and renal calculi, cancer and blastoma,
allergies like hay fever, and the risk for any physical disease.
However, after Holm–Bonferroni correction, only the associa-
tion of depressive symptoms with arthrosis and arthritis remained
(OR= 1.79, 95% CI= 1.28-2.50).
DISCUSSION
The aim of the present analyses was to estimate the association
between depressive symptoms and physical diseases in a rep-
resentative population sample in Switzerland. The presence of
depressive symptoms was associated with an increased risk for
any physical disease and after correcting for multiple testing with
an increased risk for arthrosis and arthritis.
To the best of our knowledge, this is the first study to deter-
mine the pattern of comorbidity of depressive symptoms and
physical diseases in Switzerland. Our results are in line with
previous studies reporting associations between depression and
physical diseases in general (66–70) and associations between
depression and arthrosis and arthritis (6, 11, 71, 72) in partic-
ular. Moreover, our findings are in line with findings on the
high prevalence of depression in patients with different physical
diseases (26), as well as in patients with musculoskeletal disor-
ders, such as osteoarthritis and rheumatoid arthritis (11, 12).
In addition, a recent meta-analysis confirmed the high preva-
lence of depression in patients with rheumatoid arthritis (13).
However, our findings are not in line with previous studies
reporting comorbid depressive symptoms in patients with car-
diovascular disease (18, 73), diabetes (9, 10), or COPD (16, 17).
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However, this might be due to a relatively lower statistical power
and related less precise estimation of comorbidity for those
physical diseases under study with lower prevalence (including,
stomach and duodenal ulcer, COPD and emphysema, myocar-
dial infarction, apoplexy, renal disease and calculi, cancer, and
blastoma).
Due to the cross-sectional nature of this study, we are not able to
draw conclusions about the causality of the estimated associations.
We consider three different models to explain the estimated asso-
ciations: (A) depressive symptoms may lead to physical diseases,
more specifically to arthrosis and arthritis; (B) physical diseases,
among other arthrosis and arthritis, may lead to depressive symp-
toms; (C) there may be common factors leading to both depressive
symptoms and physical diseases, especially arthrosis and arthritis.
With regard to (A), it has been shown that depressive symptoms
cause disability (1) and are related to a loss of interest in everyday
activities (74). Moreover, depressive symptoms have been associ-
ated with unfavorable health behavior, such as smoking (75, 76).
Therefore, one may speculate that depressive symptoms may, via
unfavorable health behavior, pave the way for chronic physical
disease. More specifically, depression is related to reduced physical
activity (77) and that has been associated with musculoskeletal
disorders, such as osteoarthritis (12).
With regard to (B), one may speculate that having a chronic
physical disease decreases quality of life (78, 79), which might
affect the mental health status of a person with a physical dis-
ease (23, 80, 81) resulting in reduced subjective well-being and
ability to cope with everyday life in individuals with poor mental
health (82). The perception of being unable to cope with every-
day requirements has been associated with depression (83, 84) and
this might lead to a loss of interest in daily activities, resulting in
decreased positive reinforcement to participate in everyday life,
which has been associated with depression (85, 86). More specif-
ically, arthrosis and arthritis have been associated with reduced
physical activity (87) and it has been shown that physical activ-
ity has a beneficial effect on depressive symptoms (88–90). Thus,
arthrosis and arthritis might therefore favor the development of
depressive symptoms.
With regard to (C), we can only speculate about potential
further factors. Interestingly, different immune parameters, such
as cytokines, have been associated with both depressive symp-
toms (91) and physical diseases (68, 92). Whether these para-
meters represent mediators of the observed associations or com-
mon risk factors for depression and physical diseases is largely
unknown. Thus, further research is needed to scrutinize the
mechanisms underlying the association between depression and
physical diseases.
Our analysis has several strengths: first, we included a rep-
resentative population sample totaling 14,348 subjects. Second,
the presence of physical diseases was verified by receiving treat-
ment from a medical doctor. Third, we controlled for potential
confounders that have been previously linked to depression (56–
58) and physical diseases (59). Finally, we corrected for multiple
testing, as recommended (93–95).
This study also has limitations and our findings need replica-
tion in an independent dataset. First, the non-response rate within
the SHS might have caused a selection bias (96). Therefore future
studies aiming to a higher response rate are needed in Switzerland.
Second, we were not able to determine the severity of depressive
symptoms and any of the physical diseases, as this information was
not available from the SHS data. This might have led to underesti-
mation of conditions present in the general population. Therefore,
studies precisely aiming to investigate the prevalence and sever-
ity of depressive symptoms and depressive disorders, as well as
physical diseases, in the general population are urgently needed in
Switzerland. Future studies should allow for the detection of subtle
variations of depressive symptoms in the general population, and
estimate how these variations relate to comorbidity with physical
diseases. Third, physical diseases were assessed with a self-report
checklist. However, comparable checklists highly accorded with
medical records (53, 54) and showed better accuracy than con-
sultation rates in national studies (55). Furthermore, all data on
physical diseases and corresponding disease categories were prede-
fined in the SHS. Thus, we were not able to analyze the conditions
arthrosis and arthritis as separate diagnoses, as this information
was not available from the SHS data. However, both conditions are
diseases of the musculoskeletal system and connective tissue and
involve similar symptoms, such as pain and inflammation (97).
With regard to generalizability of the findings, caution is war-
ranted. It is questionable whether our findings on the association
between depressive symptoms and physical diseases in Switzer-
land are applicable to other high-income countries because of
Switzerland’s high performing health care system (34). However,
our results on the association between depressive symptoms and
arthrosis and arthritis in Switzerland do not substantially dif-
fer from representative community-based results in Canada (7),
which is also a high-income country (32).
Due to the cross-sectional nature of our study, we abstained
from expressing a clear preference for one of the possible expla-
nations given for the associations between depressive symptoms
and any physical diseases, respectively, arthrosis and arthritis. In
this study, depressive symptoms were associated with any physical
disease and depressive symptoms were related to an increased risk
for arthrosis and arthritis. Our findings may contribute to a better
understanding of the comorbidity of depressive symptoms and
physical diseases, as well as provide the basis for a better under-
standing of the changes of mental–physical comorbidity over time
in Switzerland. We found that depressive symptoms were related to
arthrosis and arthritis, which might have implications for clinical
practice. They suggest considering to encourage the screening of
subjects with arthrosis and arthritis for depressive symptoms and
vice versa. Early recognition of the co-occurrence of depressive
symptoms with arthrosis or arthritis might allow for an improved
coordination of interdisciplinary treatment (specialized therapies
depending on the outcome of the screening) and this may posi-
tively influence the course of both conditions. Treatment costs of
physical diseases are higher for subjects with co-occurring depres-
sive symptoms than for subjects without depressive symptoms
suffering from the same disease (39–41). Thus, knowledge about
the comorbidity of depression and physical diseases may allow a
more comprehensive estimate of the overall costs related to depres-
sion. Therefore, our results might have implications for more
precise future estimates of costs related to depression, including
secondary costs, related to increased expenditures for co-occurring
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physical conditions in Switzerland. Additionally, by accounting for
co-occurrence of comorbid conditions, double counting can be
avoided (1), which might contribute to more precise future esti-
mates for costs of co-occurring depressive symptoms and physical
diseases.
Future studies should focus on the mechanisms underlying
the association between depressive symptoms and the increased
risk for physical disease in general and arthrosis and arthritis in
particular.
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